EP3209286
NOVEL PHARMACEUTICAL FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.10.2015EP published:
18.10.2023EP application number:
15791011.8
EPO information:
European Patent Register
Max expiry date:
20.10.2035
Title in English:
NOVEL PHARMACEUTICAL FORMULATIONLanguage of the patent:
English
Timeline
Today
21.10.2015EP application
18.10.2023EP Publication
Owner
Name:
RB Health (US) LLCAddress:
399 Interpace Parkway, Parsippany, NJ 07054, US
Inventor
Name:
CAVATUR, RaghuAddress:
Parsippany, New Jersey 07504, US
Name:
CHEN, KevinAddress:
Parsippany, New Jersey 07504, US
Name:
KASER, Matthew JamesAddress:
Parsippany, New Jersey 07504, US
Name:
QIU, HongchunAddress:
Basking Ridge, New Jersey 07920, US
Priority
Number:
201462066532 PDate:
21.10.2014Country:
US
Number:
201506755Date:
21.4.2015Country:
GB
Classification
Categories:
A61K 9/24, A61K 9/20, A61K 31/09, A61K 31/192, A61K 31/137, A61K 31/485, A61K 45/06, A61P 11/00, A61P 11/10, A61P 11/14